Microsatellite Stable Colorectal Carcinoma

Microsatellite Stable Colorectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

24 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 6%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05518032	Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)	withdrawn	Phase 2	0	Roswell Park Cancer InstituteOTHER	1	Sep 26, 2024	clinicaltrials
NCT03576963	Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer	withdrawn	Phase 1 / Phase 2	0	University of Southern CaliforniaOTHER	1	Apr 5, 2021	clinicaltrials